Diabet2 s.r.o.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials
• Obesity1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Suspended1 trial

Lead sponsor

• Novo Nordisk A/S2 trials
• Anji Pharma1 trial

Closed trials

• Completed

  A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

  NCT05514535· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

  NCT05013229· Phase 3· Novo Nordisk A/S· Source